Established · publishing since 1973Rising activity
Head and Neck Cancer StudiesRNA modifications and cancerCancer Genomics and DiagnosticsCervical Cancer and HPV ResearchCancer-related Molecular Pathways
Publications
663
Citations
72,722
Est. group size
~18
Recurring co-author estimate
Active years
53
Publishing since 1973
In context
Among 4,953 established Medicine PIs within our index
Citations: 72,722p25 789 · p75 7,423 · cohort median 2,544
Publications / year (recent): 31.8p25 2 · p75 10.6 · cohort median 4.8
Typically publishes in teams of ~12 · 4% small-team papers (≤3 authors) · across 20 venues
Publication cadence
Publications per year over the last 10 years — averaging 31.8/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- Development of an algorithm to assess unmeasured symptom severity in gynecologic care
UNC Libraries · 2024
- Lack of the human choline transporter‐like protein SLC44A2 causes hearing impairment and a rare red blood phenotype
EMBO Molecular Medicine · 2023
- Supplementary Table S1 from Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck Cancer
2023
- Supplementary Figure 1 from Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites
2023
- Supplementary Tables 1-4 from Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites
2023
- Data from Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck Cancer
2023
- Data from Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck Cancer
2023
- Data from Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites
2023
- Data from Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites
2023
- Supplementary Table S1 from Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck Cancer
2023
- Supplementary Tables 1-4 from Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites
2023
- Supplementary Figure 1 from Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites
2023
- Data from Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
2023
- Supplementary figures 1-6 from Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
2023
- Supplementary Table 2 from Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
2023
Publishes in
- Nature Communications×22
- Cell Reports×13
- Head & Neck×13
- Nature×12
- Cancer Research×12
Similar researchers
By research-topic overlap
- Chandan Bhambhani
Medicine · University of Michigan
- Mark E. Prince
Medicine · University of Michigan
- J. Chad Brenner
Medicine · University of Michigan
- Catherine T. Haring
Medicine · The Ohio State University
- Collin Brummel
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile